趋化因子CXCL12及受体CXCR4与肿瘤的发生及转移
被引量:2
摘要
趋化因子(chemotactic factor)是一类对白细胞具有吸引趋化作用的细胞因子,也是一类可诱导的促炎细胞因子,是细胞因子超家族成员中一类小分子蛋白多肽,由机体内淋巴细胞、巨噬细胞、间质细胞等多种组织细胞分泌产生。趋化因子受体是一类介导趋化因子行使功能的G-蛋白偶联跨膜受体(G protein couple receptor,GPCR),通常表达于免疫细胞、
出处
《中华普通外科学文献(电子版)》
2010年第2期52-53,共2页
Chinese Archives of General Surgery(Electronic Edition)
参考文献21
-
1Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature, 2001, 410(6824): 50-56.
-
2Smith JR, Falkenhagen KM, Coupland SE, et al. Malignant B cells from patients with primary central nervous system lymphoma express stroreal cell-derived factor-1. Am J Clin Pathol, 2007, 127(4): 633-641.
-
3Alsayed Y, Ngo H, Runnels J, et al. Mechanisms of regulation of CX-CR4/SDF-1 (CXCL12) dependent migration and homing in multiple myeloma. Blood, 2007, 109(7): 2708-2717.
-
4Kucia M, Reca R, Miekus K, et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms:Pivotal role of the SDF-1/CXCR4 axis. Stem cells, 2005, 23(7): 879- 894.
-
5Corcoran KE, Trzaska KA, Fernandes H, et al. Mesenchymal stem cells in early entry of breast cancer into bone marrow. PLoS One, 2008, 3(6): e2563.
-
6Muehlberg FL, Song YH, Krohn A, et al. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis, 2009, 30(4): 589-597.
-
7Tamamura H, Hori A, Kanzaki N, et al. T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer. FEBS Lett, 2003, 550(123): 79-83.
-
8Tavazoie SF, Alarcon C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature, 2008, 451 (7175): 147-152.
-
9Libura J, Drukala J, Majka M, et al. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis , and adhesion. Blood, 2002, 100(7): 2597-2606.
-
10Phillips RJ, Burdick MD, Lutz M, et al. The SDF-1/CXCL12/CXC4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med, 2003, 167(12): 1676-1686.
二级参考文献40
-
1Kodama J, Hasengaowa, Seki N, Kusumoto T, Hiramatsu Y. Expression of the CXCR4 and CCR7 chemokine receptors in human endometrial cancer. Eur J Gynaecol Onco12007; 28:370-375
-
2Pan J, Mestas J, Burdick MD, Phillips RJ, Thomas GV, Reckamp K, Belperio JA, Strieter RM. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol Cancer 2006; 5: 56
-
3Engl T, Relja B, Marian D, Blumenberg C, Mtiller I, Beecken WD, Jones J, Ringel EM, Bereiter-Hahn J, Jonas D, Blaheta RA. CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. Neoplasia 2006; 8: 290-301
-
4Salvucci O, Bouchard A, Baccarelli A, Deschenes J, Sauter G, Simon R, Bianchi R, Basik M. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res Treat 2006; 97:275-283
-
5Scala S, Ottaiano A, Ascierto PA, Cavalli M, Simeone E, Giuliano P, Napolitano M, Franco R, Botti G, Castello G. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res 2005; 11:1835-1841
-
6Ishigami S, Natsugoe S, Nakajo A, Tokuda K, Uenosono Y, Arigami T, Matsumoto M, Okumura H, Hokita S, Aikou T. Prognostic value of CCR7 expression in gastric cancer. Hepatogastroenterology 2007; 54:1025-1028
-
7Mashino K, Sadanaga N, Yamaguchi H, Tanaka F, Ohta M, Shibuta K, Inoue H, Mori M. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 2002; 62:2937-2941
-
8Wilson JL, Burchell J, Grimshaw MJ. Endothelins induce CCR7 expression by breast tumor cells via endothelin receptor A and hypoxia-inducible factor-1. Cancer Res 2006; 66:11802-11807
-
9Heresi GA, Wang J, Taichman R, Chirinos JA, Regalado JJ, Lichtstein DM, Rosenblatt JD. Expression of the chemokine receptor CCR7 in prostate cancer presenting with generalized lymphadenopathy: report of a case, review of the literature, and analysis of chemokine receptor expression. Urol Onco12005; 23:261-267
-
10Mori T, Kim J, Yamano T, Takeuchi H, Huang S, Umetani N, Koyanagi K, Hoon DS. Epigenetic upregulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. Cancer Res 2005; 65:1800-1807
共引文献16
-
1吴继,白冰,徐振晔,赵晓珍,许能.CXCR4-CXCL12轴在肺癌中的表达及临床意义[J].实用中西医结合临床,2008,8(5):1-2. 被引量:2
-
2郭清,吉向丽,吴小华,范红伟.稳定表达趋化因子受体CXCR4卵巢癌细胞株的建立与鉴定[J].第四军医大学学报,2008,29(23):2148-2151. 被引量:4
-
3吴继,白冰,徐振晔,王中奇,赵晓珍.肺岩宁方对Lewis肺癌小鼠趋化因子CXCL12及其受体CXCR4表达的影响[J].中西医结合学报,2009,7(2):125-129. 被引量:5
-
4王新均,唐俊明,孔霞,郭凌郧,杨建业,郑飞,陈龙,黄永章,王家宁.不同检测体系下骨髓源间充质干细胞迁移特征的比较[J].中国实验血液学杂志,2009,17(2):404-407. 被引量:1
-
5崔兴,王军强,刘寨东,徐瑞荣.白血病干细胞与SDF-1/CXCR4生物学轴关系的研究进展[J].医学综述,2009,15(18):2723-2726.
-
6陈钢,王洲,刘相燕.CXCR4、CCR7及其配体与非小细胞肺癌器官特异性转移的研究进展[J].中国肺癌杂志,2009,12(10):1110-1114.
-
7章大谦,吴广胜.SDF-1/CXCR4轴与髓外白血病[J].医学综述,2009,15(22):3397-3399.
-
8黄小梅,朱晓群,卢林明,刘银华,邵金贵.胃癌组织中SDF-1的表达及临床意义[J].皖南医学院学报,2010,29(2):89-91. 被引量:2
-
9陆守荣,茆勇,郁皓,吴玉玉,黄猛,吴二斌,马凤锦,华东.低分子肝素对人胃癌裸鼠原位移植模型肿瘤生长、转移及趋化因子受体4表达的影响[J].肿瘤,2010,30(7):591-595. 被引量:4
-
10张曦,王占聚,崔为发,禚沅珍,闫勇,杨明华,赵莎莎,曾春梅.急性白血病患者血清及脑脊液中SDF-1α的检测及其临床意义[J].当代医学,2011,17(8):48-49. 被引量:4
同被引文献14
-
1霍胜军,汤恢焕,魏伟.CXCL12及受体CXCR4在胆管癌中的表达及其临床意义[J].现代生物医学进展,2008,8(4):658-660. 被引量:8
-
2费立明,王长亮,赵文华,崔凯,张波,周武元,仲伟霞,李胜.CXCL12及其受体CXCR4在胰腺癌中的表达及其与淋巴管生成的相关性[J].中华外科杂志,2009,47(10):783-786. 被引量:2
-
3程继荣,王淑琴,祖木热提,邹静.肺癌组织中CD133和CD105的表达及其临床意义[J].肿瘤,2010,30(4):334-337. 被引量:4
-
4李小卫,姚宝忠,李展宇,杨颖秋,苏远航,岑宏,汤聪.CD133、β-catenin在胰腺癌中的表达及其临床关联性[J].中华普通外科学文献(电子版),2011,5(2):20-23. 被引量:9
-
5段彦龙,夏修贤,龙杏林,卓家良,陈志峰,蒋国诚.治疗儿童Ⅳ期结外鼻型NK/T细胞淋巴瘤一例报告并文献复习[J].中华血液学杂志,2011,32(10):701-703. 被引量:2
-
6姚林亚,张士伟,郭宏骞.输尿管弥漫性大B细胞淋巴瘤一例[J].江苏医药,2013,39(17):2097-2098. 被引量:7
-
7郑荣立,姜玉杰,王欣.非霍奇金淋巴瘤耐药相关microRNA研究进展[J].中国实验血液学杂志,2014,22(5):1490-1494. 被引量:4
-
8秦贝贝,李亚青,李小丽,路礼莎,张旭东,张明智.Wnt/β-catenin通路关键分子在NK/T细胞淋巴瘤组织中的表达及其临床意义[J].吉林大学学报(医学版),2015,41(2):230-234. 被引量:12
-
9徐立业,刘增辉,李薇,高玉彤.CCL22、IL-10和FOXP3在B细胞非霍奇金淋巴瘤组织中的表达及意义[J].山东医药,2015,55(14):59-61. 被引量:8
-
10张琰琰,高波,段月勋,邓刚,杨倩,王霖,吴彭春,张林,孙晶晶,潘云.HIV感染相关性弥漫大B细胞淋巴瘤患者组织中miRNA表达谱的初步研究[J].中华血液学杂志,2015,36(4):337-340. 被引量:11
引证文献2
-
1姚宝忠,李良,江鸣,张军,鲁俊.CD133和趋化因子受体4在胰腺癌中的表达及临床相关性[J].中华普通外科学文献(电子版),2017,11(6):375-379. 被引量:1
-
2王健红,刘芳,段晓辉,郝彩霞,刘祥祥,鲁英娟,王哲,梁蓉.MiR-30b通过靶向CCL22调控人NK/T细胞淋巴瘤细胞株SNK-6和YTS顺铂耐受的研究[J].中国实验血液学杂志,2019,27(6):1838-1844. 被引量:1
二级引证文献2
-
1曹威,程梦秋,陈博.CXCL12/CXCR4表达情况与胰腺癌相关性的Meta分析[J].中国循证医学杂志,2021,21(2):179-185. 被引量:2
-
2段晓晖,李宏,吕垚,刘静,王世雄,吴振天,王冰璇,卢铭,王健红,梁蓉.黄芩苷通过FOXO3/CCL22信号通路调控结外NK/T细胞淋巴瘤细胞生长的机制研究[J].中国实验血液学杂志,2023,31(3):730-738. 被引量:1
-
1陈丽云,郑丽华,罗飞,苏素文.炎症在卵巢癌发病中的作用研究进展[J].现代中西医结合杂志,2015,24(32):3646-3648. 被引量:5
-
2李娅茹,冯玉珍.Lgr5与卵巢癌关系的研究进展[J].河北医科大学学报,2015,36(12):1486-1488. 被引量:7
-
3冯艳,贺晶.G蛋白偶联受体30在宫颈癌组织中的表达及临床意义[J].解放军医药杂志,2016,28(10):50-53. 被引量:13
-
4尚颖,赵立元,陆景坤.炎性细胞因子与胃癌的关系[J].中国药科大学学报,2015,46(1):123-128. 被引量:31
-
5S.Mitsunaga,戴欣,赵红川.晚期胰腺癌恶病质IL-6所扮演的角色[J].肝胆外科杂志,2010,18(4):319-320.
-
6张淑兰,于艺,姜涛,林蓓,高红.卵巢上皮性癌组织中KiSS-1基因及其受体GPR54 mRNA的表达及其意义[J].中华妇产科杂志,2005,40(10):689-692. 被引量:11
-
7沈坤堂,侯英勇,秦新裕,宋陆军,宿杰阿克苏.甲磺酸伊马替尼靶向治疗晚期胃肠道间质瘤[J].中华胃肠外科杂志,2005,8(2):129-131. 被引量:12
-
8潘刘翃,姚敏,姚登福.Wnt信号通路表达异常对肝炎、肝细胞肝癌的临床意义[J].中华肝脏病杂志,2015,23(10):797-800. 被引量:4
-
9郑丽华,程忠平.雌激素跨膜受体GPR30及其在子宫内膜癌和卵巢癌中的研究进展[J].国际妇产科学杂志,2014,41(4):395-400. 被引量:3
-
10冯毅,龚建平.HMGB-1在脓毒症及肿瘤中的作用[J].国际外科学杂志,2007,34(6):384-388. 被引量:1